Separating Fact From Fallacy in Celiac Disease
Clinicians summarized the current research and clarified widespread misinformation on celiac disease.
Inflammatory Bowel Diseases (IBD)
Corticosteroid Use Declines in Patients With IBD Over Past 20 Years
Investigators assessed trends in corticosteroid use in patients with IBD over a period of 20 years.
IBD and Osteoporosis: Key Takeaways and New Data
Reviewing a patient’s potential risk for osteoporosis should be a routine part of each visit for patients with IBD.
Spirulina Supplementation Improves Quality of Life for Patients With Ulcerative Colitis
Investigators examined the effects of spirulina on anthropometric parameters, blood pressure, and quality of life measures in patients with ulcerative colitis.
Inflammatory Proteins Highly Predictive of UC Diagnosis
Investigators aimed to characterize the systemic, preclinical inflammatory immune response of UC using a comprehensive set of proteins.
Microscopic Colitis: Is Vedolizumab An Option?
Due to the relatively high relapse rate and need for additional therapies, current research is being done on the use of Vedolizumab for the treatment of microscopic colitis.
Risankizumab Safe, Effective for Long-Term Treatment of Crohn Disease
Investigators conducted an open-label extension to evaluate the long-term safety and efficacy of risankizumab for the treatment of moderate to severe Crohn disease.
Perianal Crohn Disease Is a Strong Predictor of a Complicated Disease Course
Researchers evaluated perianal involvement in patients with CD and compared disease course in those with severe vs non-severe perianal CD.
Low FODMAP Diet and IBD: A Potential Option?
Current research indicates that short-term utilization of an LFD may help ameliorate some mild IBS symptoms associated with quiescent IBD, while further long term studies are still needed.
Marijuana and IBD: Challenging Decisions
Though patient use of cannabinoids for the treatment of IBD has increased, clinical decision making on whether to formally recommend it as treatment remains difficult.
- Loading...
Loading...
Loading... 
Loading...